Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Pediatric parkinsonism (PP) is a rare but disabling movement disorder characterized by bradykinesia and rigidity, with tremor being less frequent. Additional features include gait disturbances and impaired postural reflexes. In younger children, hypotonia is often a predominant sign. Clinical expression evolves with neurodevelopment and is frequently associated with other movement abnormalities, such as dystonia. The condition may arise from a variety of pathophysiological mechanisms and multiple etiologies, with genetic causes being particularly prominent. A classification system has been proposed based on age of onset, clinical features, prognosis and etiology, comprising: Developmental parkinsonism, Infantile degenerative parkinsonism, Parkinsonism in the setting of postnatal neurodevelopmental disorders, Parkinsonism associated with multisystemic brain diseases, Juvenile parkinsonism and dystonia-parkinsonism and Acquired parkinsonism. A specific assessment tool-the Infantile Parkinsonism-Dystonia Rating Scale-has recently been developed and primarily validated to quantify severity, monitor disease progression and assess treatment response. This review aims to provide a comprehensive overview of the clinical features, pathophysiology, etiologies and treatment approaches of pediatric parkinsonism. In addition, we propose a diagnostic algorithm to support clinical decision-making.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.